Original paper
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population
Abstract
Background Kirsten rat sarcoma viral oncogene (KRAS) G12C mutation occurs in about 4% of colorectal cancers (CRCs). Recently, KRAS G12C was identified to be a potential drug target and predictor of response to the novel on AMG510 target treatment. We described the clinicopathologic features and prognosis of KRAS G12C-mutated metastatic CRCs compared to other KRAS mutation. Patients and Methods Clinicopathologic features and outcome data of...
Paper Details
Title
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population
Published Date
Sep 1, 2020
Journal
Volume
19
Issue
3
Pages
219 - 225
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History